University of Lagos Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01152931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

College of Medicine, University of Lagos | College of Medicine, University of Lagos, Idi-araba, Nigeria | Deparment of Pharmacology, College of Medicine, University of Lagos, Nigeria | Department of Pharmacology, College of Medicine University of Lagos, Nigeria | University of Lagos | University of Lagos, Nigeria | Uzoma Chinyei Joan

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Malaria (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 21